Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$0.38 - $0.64 $4,360 - $7,344
-11,475 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$0.55 - $0.98 $108,083 - $192,584
-196,515 Reduced 94.48%
11,475 $8,000
Q4 2021

Feb 15, 2022

BUY
$0.9 - $1.31 $187,191 - $272,466
207,990 New
207,990 $205,000
Q2 2021

Aug 16, 2021

SELL
$1.6 - $2.02 $42,432 - $53,570
-26,520 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$1.86 - $2.87 $49,327 - $76,112
26,520 New
26,520 $53,000
Q3 2020

Nov 17, 2020

SELL
$1.6 - $2.35 $793,854 - $1.17 Million
-496,159 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$1.33 - $2.76 $334,218 - $693,565
251,292 Added 102.62%
496,159 $1.15 Million
Q1 2020

May 15, 2020

BUY
$0.97 - $2.85 $237,520 - $697,870
244,867 New
244,867 $379,000
Q3 2019

Nov 14, 2019

SELL
$0.61 - $2.21 $286,253 - $1.04 Million
-469,268 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$0.51 - $0.86 $239,326 - $403,570
469,268 New
469,268 $306,000
Q1 2019

May 16, 2019

SELL
$0.51 - $0.82 $10,133 - $16,293
-19,870 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$0.48 - $1.1 $9,537 - $21,857
19,870 New
19,870 $10,000
Q2 2018

Aug 15, 2018

SELL
$1.56 - $2.51 $76,170 - $122,555
-48,827 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$0.91 - $2.24 $31,172 - $76,731
34,255 Added 235.07%
48,827 $104,000
Q4 2017

Feb 15, 2018

BUY
$0.78 - $2.1 $11,366 - $30,601
14,572
14,572 $13,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $223M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.